Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Reiberger

Showing results (101-110 of 490) with videos related to

Pageof 49
Sort By:
Journal of Hepatology|February 5, 2022
Baveno VII - Renewing consensus in portal hypertensionRoberto de Franchis, Jaime Bosch, Guadalupe Garcia-Tsao, et al.
Journal of Hepatology|September 30, 2024
Bile acid metabolism and signalling in liver diseaseClaudia D Fuchs, Benedikt Simbrunner, Maximillian Baumgartner, et al.
Journal of Hepatology|August 25, 2023
Reply to: "Ammonia predicts clinical outcomes in cirrhosis - but there are caveats to consider"Maria Pilar Ballester, Juan Antonio Carbonell-Asins, Lorenz Balcar, et al.
Journal of Visualized Experiments : Jove|August 21, 2018
Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic RatsPhilipp Königshofer, Ksenia Brusilovskaya, Philipp Schwabl, et al.
The Journal of Infectious Diseases|August 6, 2013
Reversion and conversion of interferon-γ release assay results in HIV-1-infected individualsMaximilian C Aichelburg, Thomas Reiberger, Florian Breitenecker, et al.
Journal of Hepatology|August 4, 2025
Establishing hepatic decompensation as a meaningful clinical outcome during systemic therapy for hepatocellular carcinomaGiuseppe Cabibbo, Ciro Celsa, Sherrie Bhoori, et al.
Journal of Clinical Microbiology|May 18, 2012
Prognostic value of indeterminate IFN-γ release assay results in HIV-1 infectionMaximilian C Aichelburg, Julia Tittes, Florian Breitenecker, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 27, 2025
Course of Portal Hypertension and Applicability of Noninvasive Tests After Recompensation in Alcohol-related CirrhosisBenedikt Silvester Hofer, Georg Semmler, Benedikt Simbrunner, et al.
Journal of Hepatology|March 20, 2022
Immediate-type hypersensitivity reaction to bulevirtide and successful desensitization in a patient with HBV/HDV-associated compensated cirrhosisCaroline Schwarz, David Chromy, Christine Bangert, et al.
Trials|April 24, 2023
The rationale and study design of two phase II trials examining the effects of BI 685,509, a soluble guanylyl cyclase activator, on clinically significant portal hypertension in patients with compensated cirrhosisThomas Reiberger, Annalisa Berzigotti, Jonel Trebicka, et al.
Pageof 49

Showing results (101-110 of 490) with videos related to

Sort By:
Pageof 49
Journal of Hepatology|February 5, 2022
Baveno VII - Renewing consensus in portal hypertensionRoberto de Franchis, Jaime Bosch, Guadalupe Garcia-Tsao, et al.
Journal of Hepatology|September 30, 2024
Bile acid metabolism and signalling in liver diseaseClaudia D Fuchs, Benedikt Simbrunner, Maximillian Baumgartner, et al.
Journal of Hepatology|August 25, 2023
Reply to: "Ammonia predicts clinical outcomes in cirrhosis - but there are caveats to consider"Maria Pilar Ballester, Juan Antonio Carbonell-Asins, Lorenz Balcar, et al.
Journal of Visualized Experiments : Jove|August 21, 2018
Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic RatsPhilipp Königshofer, Ksenia Brusilovskaya, Philipp Schwabl, et al.
The Journal of Infectious Diseases|August 6, 2013
Reversion and conversion of interferon-γ release assay results in HIV-1-infected individualsMaximilian C Aichelburg, Thomas Reiberger, Florian Breitenecker, et al.
Journal of Hepatology|August 4, 2025
Establishing hepatic decompensation as a meaningful clinical outcome during systemic therapy for hepatocellular carcinomaGiuseppe Cabibbo, Ciro Celsa, Sherrie Bhoori, et al.
Journal of Clinical Microbiology|May 18, 2012
Prognostic value of indeterminate IFN-γ release assay results in HIV-1 infectionMaximilian C Aichelburg, Julia Tittes, Florian Breitenecker, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 27, 2025
Course of Portal Hypertension and Applicability of Noninvasive Tests After Recompensation in Alcohol-related CirrhosisBenedikt Silvester Hofer, Georg Semmler, Benedikt Simbrunner, et al.
Journal of Hepatology|March 20, 2022
Immediate-type hypersensitivity reaction to bulevirtide and successful desensitization in a patient with HBV/HDV-associated compensated cirrhosisCaroline Schwarz, David Chromy, Christine Bangert, et al.
Trials|April 24, 2023
The rationale and study design of two phase II trials examining the effects of BI 685,509, a soluble guanylyl cyclase activator, on clinically significant portal hypertension in patients with compensated cirrhosisThomas Reiberger, Annalisa Berzigotti, Jonel Trebicka, et al.
Pageof 49